Skip to main content

Main menu

  • Home
  • Content
    • Latest
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Alerts
    • Feedback
    • Folders
    • Help
  • Other Publications
    • Saudi Medical Journal

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Neurosciences Journal
  • Other Publications
    • Saudi Medical Journal
  • My alerts
  • Log in
Neurosciences Journal

Advanced Search

  • Home
  • Content
    • Latest
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Alerts
    • Feedback
    • Folders
    • Help
  • Follow psmmc on Twitter
  • Visit psmmc on Facebook
  • RSS
Research ArticleOriginal Article
Open Access

Outcomes and complications of patients with cerebral venous thrombosis: a retrospective study

Mosaad O. Almegren, Saleh H. Alharbi, Turki A. Alshuaibi, Mohammed M. Almansour, Khalid A. Alharbi, Bader Al Rawahi, Abdulmajeed K. Al Balushi, Abdulrahman A. Alraizah and Farjah H. Alqahtani
Neurosciences Journal January 2024, 29 (1) 32-36; DOI: https://doi.org/10.17712/nsj.2024.1.20230050
Mosaad O. Almegren
From the Department of Medicine (Almegren, Alharbi S), College of Medicine, Imam Mohammad Ibn Saud Islamic University, from the Department of Oncology (Alraizah), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, King Saud bin Abdulaziz University of Health Sciences, Riyadh, Department of Medicine (Alshuaibi, Alharbi K, Almansour), King Fahad Hospital, Jeddah, and from the Division of Hematology (Alqahtani), Department of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia, and from the Department of Hematology (Al Rawahi), College of Medicine and Health Sciences (Al Balushi), Sultan Qaboos University Hospital, Muscat, Oman.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mosaad O. Almegren
  • For correspondence: [email protected]
Saleh H. Alharbi
From the Department of Medicine (Almegren, Alharbi S), College of Medicine, Imam Mohammad Ibn Saud Islamic University, from the Department of Oncology (Alraizah), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, King Saud bin Abdulaziz University of Health Sciences, Riyadh, Department of Medicine (Alshuaibi, Alharbi K, Almansour), King Fahad Hospital, Jeddah, and from the Division of Hematology (Alqahtani), Department of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia, and from the Department of Hematology (Al Rawahi), College of Medicine and Health Sciences (Al Balushi), Sultan Qaboos University Hospital, Muscat, Oman.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Turki A. Alshuaibi
From the Department of Medicine (Almegren, Alharbi S), College of Medicine, Imam Mohammad Ibn Saud Islamic University, from the Department of Oncology (Alraizah), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, King Saud bin Abdulaziz University of Health Sciences, Riyadh, Department of Medicine (Alshuaibi, Alharbi K, Almansour), King Fahad Hospital, Jeddah, and from the Division of Hematology (Alqahtani), Department of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia, and from the Department of Hematology (Al Rawahi), College of Medicine and Health Sciences (Al Balushi), Sultan Qaboos University Hospital, Muscat, Oman.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohammed M. Almansour
From the Department of Medicine (Almegren, Alharbi S), College of Medicine, Imam Mohammad Ibn Saud Islamic University, from the Department of Oncology (Alraizah), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, King Saud bin Abdulaziz University of Health Sciences, Riyadh, Department of Medicine (Alshuaibi, Alharbi K, Almansour), King Fahad Hospital, Jeddah, and from the Division of Hematology (Alqahtani), Department of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia, and from the Department of Hematology (Al Rawahi), College of Medicine and Health Sciences (Al Balushi), Sultan Qaboos University Hospital, Muscat, Oman.
MBBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Khalid A. Alharbi
From the Department of Medicine (Almegren, Alharbi S), College of Medicine, Imam Mohammad Ibn Saud Islamic University, from the Department of Oncology (Alraizah), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, King Saud bin Abdulaziz University of Health Sciences, Riyadh, Department of Medicine (Alshuaibi, Alharbi K, Almansour), King Fahad Hospital, Jeddah, and from the Division of Hematology (Alqahtani), Department of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia, and from the Department of Hematology (Al Rawahi), College of Medicine and Health Sciences (Al Balushi), Sultan Qaboos University Hospital, Muscat, Oman.
MBBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bader Al Rawahi
From the Department of Medicine (Almegren, Alharbi S), College of Medicine, Imam Mohammad Ibn Saud Islamic University, from the Department of Oncology (Alraizah), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, King Saud bin Abdulaziz University of Health Sciences, Riyadh, Department of Medicine (Alshuaibi, Alharbi K, Almansour), King Fahad Hospital, Jeddah, and from the Division of Hematology (Alqahtani), Department of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia, and from the Department of Hematology (Al Rawahi), College of Medicine and Health Sciences (Al Balushi), Sultan Qaboos University Hospital, Muscat, Oman.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abdulmajeed K. Al Balushi
From the Department of Medicine (Almegren, Alharbi S), College of Medicine, Imam Mohammad Ibn Saud Islamic University, from the Department of Oncology (Alraizah), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, King Saud bin Abdulaziz University of Health Sciences, Riyadh, Department of Medicine (Alshuaibi, Alharbi K, Almansour), King Fahad Hospital, Jeddah, and from the Division of Hematology (Alqahtani), Department of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia, and from the Department of Hematology (Al Rawahi), College of Medicine and Health Sciences (Al Balushi), Sultan Qaboos University Hospital, Muscat, Oman.
MBBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abdulrahman A. Alraizah
From the Department of Medicine (Almegren, Alharbi S), College of Medicine, Imam Mohammad Ibn Saud Islamic University, from the Department of Oncology (Alraizah), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, King Saud bin Abdulaziz University of Health Sciences, Riyadh, Department of Medicine (Alshuaibi, Alharbi K, Almansour), King Fahad Hospital, Jeddah, and from the Division of Hematology (Alqahtani), Department of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia, and from the Department of Hematology (Al Rawahi), College of Medicine and Health Sciences (Al Balushi), Sultan Qaboos University Hospital, Muscat, Oman.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Farjah H. Alqahtani
From the Department of Medicine (Almegren, Alharbi S), College of Medicine, Imam Mohammad Ibn Saud Islamic University, from the Department of Oncology (Alraizah), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, King Saud bin Abdulaziz University of Health Sciences, Riyadh, Department of Medicine (Alshuaibi, Alharbi K, Almansour), King Fahad Hospital, Jeddah, and from the Division of Hematology (Alqahtani), Department of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia, and from the Department of Hematology (Al Rawahi), College of Medicine and Health Sciences (Al Balushi), Sultan Qaboos University Hospital, Muscat, Oman.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • References
  • PDF
Loading

References

  1. 1.↵
    1. Tadi P,
    2. Behgam B,
    3. Baruffi S.
    Cerebral venous thrombosis. In StatPearls [Internet] 2022 Jun 17. StatPearls Publishing.
  2. 2.↵
    1. Gulati D,
    2. Strbian D,
    3. Sundararajan S.
    Cerebral venous thrombosis: diagnosis and management. Stroke 2014; 45: e16–e18.
    OpenUrlFREE Full Text
  3. 3.↵
    1. Bousser MG,
    2. Ferro JM.
    Cerebral venous thrombosis: an update. Lancet Neurol 2007; 6: 162–170.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Zhou LW,
    2. Yu AY,
    3. Ngo L,
    4. Hill MD,
    5. Field TS.
    Incidence of Cerebral Venous Thrombosis: A Population-Based Study, Systematic Review, and Meta-Analysis. Stroke 2023; 54: 169–177.
    OpenUrl
  5. 5.↵
    1. Ulivi L,
    2. Squitieri M,
    3. Cohen H,
    4. Cowley P,
    5. Werring DJ.
    Cerebral venous thrombosis: a practical guide. Pract Neurol 2020; 20: 356–367.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Issar P,
    2. Chinna S,
    3. Issar SK.
    Evaluation of Cerebral Venous Thrombosis by CT, MRI and MR Venography. J Assoc Physicians India 2017; 65: 16–21.
    OpenUrl
  7. 7.↵
    1. Algahtani HA,
    2. Abdu AP,
    3. Shami AM,
    4. Hassan AE,
    5. Madkour MA,
    6. Al-Ghamdi SM, et al.
    Cerebral venous sinus thrombosis in Saudi Arabia. Neurosci J 2011; 16: 329–334.
    OpenUrl
  8. 8.↵
    1. Al Rawahi B,
    2. Almegren M,
    3. Carrier M.
    The efficacy and safety of anticoagulation in cerebral vein thrombosis: A systematic review and meta-analysis. Thromb Res 2018; 169: 135–139.
    OpenUrl
  9. 9.↵
    1. Sidhom Y,
    2. Mansour M,
    3. Messelmani M,
    4. Derbali H,
    5. Fekih-Mrissa N,
    6. Zaouali J, et al.
    Cerebral venous thrombosis: clinical features, risk factors, and long-term outcome in a Tunisian cohort. J Stroke Cerebrovasc Dis 2014; 23: 1291–1295.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Al Hashmi K,
    2. Al Wahaibi K,
    3. Al-Khabori M,
    4. Al Lamki S.
    Characteristics and outcomes of patients with cerebral venous sinus thrombosis. Oman M J 2019; 34: 434.
    OpenUrl
  11. 11.↵
    1. Ferro JM,
    2. Canhão P,
    3. Stam J,
    4. Bousser MG,
    5. Barinagarrementeria F.
    Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004; 35: 664–670.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Van Swieten JC,
    2. Koudstaal PJ,
    3. Visser MC,
    4. Schouten HJ,
    5. Van Gijn J.
    Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19: 604–607.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Daghriri HM,
    2. Alrajhi AA,
    3. Aburasain KS,
    4. Ateya EA,
    5. Hakami MA,
    6. Gosadi IM.
    An assessment of cerebral venous thrombosis risk factors and associated clinical outcomes in Jazan region, Saudi Arabia. Neurosci J 2021; 26: 15–20.
    OpenUrl
  14. 14.↵
    1. Li X,
    2. Dong J,
    3. Sun Y,
    4. Li Q,
    5. Shi L.
    Relationship between cerebral venous sinus thrombosis and intracranial arteritis during pregnancy and post partum. J Investig Med 2021; 69: 1367–1371.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Lidegaard Ø,
    2. Nielsen LH,
    3. Skovlund CW,
    4. Løkkegaard E.
    Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10. Brit Med J 2012; 344.
  16. 16.↵
    1. Wasay M,
    2. Kaul S,
    3. Menon B,
    4. Dai AI,
    5. Saadatnia M,
    6. Malik A, et al.
    Asian study of cerebral venous thrombosis. J Stroke Cerebrovasc Dis 2019; 28: 104247.
    OpenUrl
  17. 17.↵
    1. Abelhad NI,
    2. Qiao W,
    3. Garg N,
    4. Rojas-Hernandez CM.
    Thrombosis and bleeding outcomes in the treatment of cerebral venous thrombosis in cancer. Thromb J 2021; 19: 1–6.
    OpenUrlPubMed
  18. 18.↵
    1. Dentali F,
    2. Poli D,
    3. Scoditti U,
    4. Minno MD,
    5. Stefano VD,
    6. Siragusa S, et al.
    Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study. J Thromb Haemost 2012; 10: 1297–1302.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Lal D,
    2. Gujjar AR,
    3. Ramachandiran N,
    4. Obaidi A,
    5. Kumar S,
    6. El-Tigani M, et al.
    Spectrum of cerebral venous thrombosis in Oman. Sultan Qaboos Uni Med J 2018; 18: e329.
    OpenUrl
  20. 20.↵
    1. Wasay M,
    2. Khan M,
    3. Rajput HM,
    4. Farooq S,
    5. Memon MI,
    6. AlRukn SA, et al.
    New oral anticoagulants versus warfarin for cerebral venous thrombosis: a multi-center, observational study. J Stroke 2019; 21: 220.
    OpenUrlPubMed
  21. 21.↵
    1. Coutinho JM,
    2. Zuurbier SM,
    3. Stam J.
    Declining mortality in cerebral venous thrombosis: a systematic review. Stroke 2014; 45: 1338–1341.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Gasparini S,
    2. Neri S,
    3. Brigo F,
    4. Cianci V,
    5. Mammì A,
    6. Pascarella A, et al.
    Late epileptic seizures following cerebral venous thrombosis: a systematic review and meta-analysis. Neurol Sci 2022; 43: 5229–5236.
    OpenUrl
  23. 23.↵
    1. Stolz E,
    2. Rahimi A,
    3. Gerriets T,
    4. Kraus J,
    5. Kaps M.
    Cerebral venous thrombosis: an all or nothing disease?Prognostic factors and long-term outcome. Clin Neurol Neurosurg 2005; 107: 99–107.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Duman T,
    2. Uluduz D,
    3. Midi I,
    4. Bektas H,
    5. Kablan Y,
    6. Goksel BK, et al.
    A multicenter study of 1144 patients with cerebral venous thrombosis: the VENOST study. J Stroke Cerebrovasc Dis 2017; 26: 1848–1857.
    OpenUrl
PreviousNext
Back to top

In this issue

Neurosciences Journal: 29 (1)
Neurosciences Journal
Vol. 29, Issue 1
1 Jan 2024
  • Table of Contents
  • Cover (PDF)
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Neurosciences Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Outcomes and complications of patients with cerebral venous thrombosis: a retrospective study
(Your Name) has sent you a message from Neurosciences Journal
(Your Name) thought you would like to see the Neurosciences Journal web site.
Citation Tools
Outcomes and complications of patients with cerebral venous thrombosis: a retrospective study
Mosaad O. Almegren, Saleh H. Alharbi, Turki A. Alshuaibi, Mohammed M. Almansour, Khalid A. Alharbi, Bader Al Rawahi, Abdulmajeed K. Al Balushi, Abdulrahman A. Alraizah, Farjah H. Alqahtani
Neurosciences Journal Jan 2024, 29 (1) 32-36; DOI: 10.17712/nsj.2024.1.20230050

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Outcomes and complications of patients with cerebral venous thrombosis: a retrospective study
Mosaad O. Almegren, Saleh H. Alharbi, Turki A. Alshuaibi, Mohammed M. Almansour, Khalid A. Alharbi, Bader Al Rawahi, Abdulmajeed K. Al Balushi, Abdulrahman A. Alraizah, Farjah H. Alqahtani
Neurosciences Journal Jan 2024, 29 (1) 32-36; DOI: 10.17712/nsj.2024.1.20230050
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Acknowledgement
    • References
  • Figures & Data
  • eLetters
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Comment on: Outcomes and complications of patients with cerebral venous thrombosis: a retrospective study
  • Google Scholar

More in this TOC Section

  • Does the severity of facet joint osteoarthritis affect facet medial branch radiofrequency thermocoagulation results?
  • Thunderclap headache management among Emergency Department visitors in tertiary care center in Makkah City: Retrospective cohort study
  • Do people with multiple sclerosis in Saudi Arabia want to know their prognosis? A cross-sectional nationwide study
Show more Original Article

Similar Articles

Navigate

  • home

More Information

  • Help

Additional journals

  • All Topics

Other Services

  • About

© 2025 Neurosciences Journal Neurosciences is copyright under the Berne Convention and the International Copyright Convention. All rights reserved. Neurosciences is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3183. Print ISSN 1319-6138.

Powered by HighWire